Treatment of elderly and unfit patients with CRC

MEET THE EXPERTS ALL PROGRAMMES DEVELOPED COLLABORATIONS CONTACT

Treatment of elderly and unfit patients with CRC

Prof. Hans Prenen, Asst. Prof. Joleen Hubbard

Ass. Prof. Fotios Loupakis, Prof. Hans Prenen and Ass. Prof. Joleen Hubbard discuss the Clinical Question: How to treat (or not) elderly colorectal cancer patients? Unfit: a relative concept

Prof. Hans Prenen

Medical Oncologist

University Hospital Antwerp

Belgium

Asst. Prof. Joleen Hubbard

Medical Oncologist

Mayo Cinic Rochester

United States (US)

time | open 5 min | 2016

download resources

Download the slides

I agree that this educational programme:

GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.

Other programmes of interest

The Role of the Nurse in nmCRPC Patient Management

Mar 2023

Podcast: Advanced HCC and not eligible for IO - what are the trea...

Mar 2023

Exploring the current gastroesophageal cancer treatment landscape...

Mar 2023

Podcast: PARP inhibitors alone or in combination with novel hormo...

Feb 2023

Systemic Therapies in Endometrial Carcinoma

Feb 2023

Update from ASCO GI

Jan 2023

Accreditation: EACCME

PARP inhibitors in prostate cancer and the rationale behind combi...

Jan 2023

Optimising treatment sequencing for mCRC, third line and beyond

Jan 2023

Highlights from CTOS 2022

Jan 2023

Update From ASH 2022

Dec 2022

Targeted and Immunotherapies for Advanced Renal Cell Carcinoma

Dec 2022

Update From San Antonio Breast Cancer Symposium 2022

Dec 2022

Other programmes developed by Prof. Hans Prenen

Prof. Hans Prenen

Medical Oncologist

University Hospital Antwerp

Belgium

Early-onset Colorectal Cancer

Nov 2022

Podcast: management of skin toxicity with multikinase inhibitors

Jun 2022

GI CONNECT Update from ECC 2015: cancers of the upper GI tract

2015

What is the future of immunotherapy in colorectal cancer?

2018

Other programmes developed by Asst. Prof. Joleen Hubbard

Asst. Prof. Joleen Hubbard

Medical Oncologist

Mayo Cinic Rochester

United States (US)

Review paper on K-Ras targeted therapy in GI cancer

2018

GI CONNECT update from ASCO GI 2016: cancers of the upper GI trac...

2016

GI CONNECT Update from ASCO GI 2017: cancers of the lower GI trac...

2017

GI CONNECT update from ASCO and WCGIC 2017: cancers of the upper ...

2017

Which targeted drug (bevacizumab, ramucirumab, aflibercept, or an...

2017

Do we need adjuvant treatment after surgical resection of colorec...

2017

GI CONNECT Update from ASCO and WCGIC 2018: cancers of the upper ...

2018

Non-surgical management of early stage rectal cancer

2019

GI CONNECT CRC Masterclass: accredited elearning, slides and summ...

2019

How do we identify and treat patients with BRAF-mutated mCRC?

Oct 2020

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.